Physician profile
Catherine M Mintzer
NPI 1013905652
$1,028.65
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2021: $18.43 · 2022: $23.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $179.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $83.31 | 2019-2021 | |
| Novo Nordisk INC | $80.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.04 | 2019 | |
| Abbvie INC. | $70.72 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $57.44 | 2019 | |
| Amgen INC. | $53.65 | 2019 | |
| Glaxosmithkline, LLC. | $47.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.70 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.06 | 2019 | |
| Therapeuticsmd, INC. | $33.55 | 2019 | |
| Endo Pharmaceuticals INC. | $30.86 | 2019 | |
| Merck Sharp & Dohme LLC | $27.74 | 2019 | |
| Lilly USA, LLC | $24.45 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.09 | 2019 | |
| Astellas Pharma US INC | $21.03 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.75 | 2019 | |
| Valeritas, INC. | $17.96 | 2019 | |
| Sanofi Pasteur INC. | $15.45 | 2019 | |
| Hikma Pharmaceuticals USA | $10.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Mintzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.